Jove
Visualize
Contact Us

Related Experiment Videos

[Anticoagulants in clinical practice].

B Boneu1

  • 1Laboratoire d'hématologie, Hôpital de Rangueil, Toulouse.

La Revue Du Praticien
|December 3, 1999
PubMed
Summary
This summary is machine-generated.

Four anticoagulant classes, including vitamin K antagonists and heparin, are available. New agents like Orgaran and hirudin address challenges with heparin-induced thrombocytopenia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidelines of the French Society for Digestive Endoscopy (SFED).

Endoscopy·2006
Same author

The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies.

Journal of thrombosis and haemostasis : JTH·2005
Same author

Long-haul flights do not activate hemostasis in young healthy men.

Journal of thrombosis and haemostasis : JTH·2005
Same author

Laboratory monitoring of low-molecular-weight heparin therapy-part II.

Journal of thrombosis and haemostasis : JTH·2005
Same author

Enhancement of enzymatic fibrinolysis with 2-MHz ultrasound and microbubbles.

Journal of thrombosis and haemostasis : JTH·2004
Same author

[Oral anticoagulant treatment: practical aspects and significance of anticoagulant clinics].

Annales de cardiologie et d'angeiologie·2002
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pharmacology
  • Thrombosis and Hemostasis

Background:

  • Four main classes of anticoagulants are currently utilized in clinical practice.
  • These include vitamin K antagonists, heparin, Orgaran, and hirudin.
  • Each class possesses distinct mechanisms of action, dosing regimens, and monitoring requirements.

Purpose of the Study:

  • To provide a comprehensive overview of available anticoagulant classes.
  • To detail the mechanism of action, typical dosages, and biological monitoring for each class.
  • To highlight the utility of newer agents like Orgaran and hirudin in managing specific clinical scenarios.

Main Methods:

  • Literature review of established and emerging anticoagulant therapies.
  • Comparative analysis of pharmacological properties and clinical applications.

Related Experiment Videos

  • Focus on practical aspects including dosing and monitoring.

    • Main Results:

    • Detailed descriptions of vitamin K antagonists and heparin, including their mechanisms and monitoring.
    • Emphasis on low molecular weight heparins as unique entities requiring individual consideration.
    • Introduction of Orgaran and hirudin as novel antithrombotic agents.

    Conclusions:

    • Understanding the distinct characteristics of each anticoagulant class is crucial for effective patient management.
    • Low molecular weight heparins necessitate specific protocols due to their unique profiles.
    • Orgaran and hirudin offer vital therapeutic alternatives for patients experiencing heparin-induced thrombocytopenia.